chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Anosmia - could not smell coffee; Some times the flavors are off/could not taste; Some body aches; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Anosmia - could not smell coffee), AGEUSIA (Some times the flavors are off/could not taste) and MYALGIA (Some body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced ANOSMIA (Anosmia - could not smell coffee), AGEUSIA (Some times the flavors are off/could not taste) and MYALGIA (Some body aches). On 03-Apr-2021, MYALGIA (Some body aches) had resolved. At the time of the report, ANOSMIA (Anosmia - could not smell coffee) and AGEUSIA (Some times the flavors are off/could not taste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.   Reporter did not allow further contact
she also had 2 Pfizer COVID boosters; and still got COVID.; she also had 2 Pfizer COVID boosters; and still got COVID.; Caller states she has had 5 Covid Shots, the First 2 were Moderna, and then a mixture of Pfizer Booster doses; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 as dose 5 (booster), single (Lot number: GH9694) at the age of 73 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 30Mar2022 as dose 4 (booster), single (Lot number: FK9895) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 12Feb2021 as dose 1, single (Lot number: 006M2014), on 12Mar2021 as dose 2, single (Lot number: 0016219) and on 22Oct2021 as dose 3 (booster), single (Lot number: 047C2114) for covid-19 immunisation. The patient's relevant medical history included: "High Blood Pressure" (ongoing); "Premature atrial contraction" (ongoing); "Cholesterol" (ongoing). Concomitant medication(s) included: DILTIAZEM taken for supraventricular extrasystoles (ongoing); ROSUVASTATIN taken for blood cholesterol (ongoing); LOSARTAN (ongoing). The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 30Mar2022, outcome "unknown", described as "Caller states she has had 5 Covid Shots, the First 2 were Moderna, and then a mixture of Pfizer Booster doses"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 21Dec2022, outcome "unknown" and all described as "she also had 2 Pfizer COVID boosters; and still got COVID.". The patient underwent the following laboratory tests and procedures: Blood pressure measurement: 112/76; Blood test: States her blood work comes out okay; Body temperature: 100.1; Heart rate: 83; SARS-CoV-2 test: negative, notes: Covid test before that and it was negative; positive, notes: The rapid test was positive. Therapeutic measures, Paxlovid,  were taken as a result of drug ineffective, covid-19.
Pt received PNEUMOVAX (R) arm, then developed red "blister," which became a nodule, gradually enlarging since.
Breakthrough case admission after 4 vaccines Moderna 2/4/21 Lot# 038K20A;  Moderna 3/4/21 Lot# 030A21a;  Moderna 12/8/21 Lot# 060H21A;  Moderna 5/13/22 Lot# 005M21A
She reports going camping 1 wk after vaccine admin. and 2 days into camping trip she develops "severe" raised generalized rash all over w/pruritis. She went to MD 1/6/15 and was put on steroid PO and had improvement in 2 days. MD diagnosed with dermatitis. her husband who was vaccinated co same time had similar but very "mild" rash that began 2 days after her's.
Client in today to report local reaction from pneumococcal vaccination given 10/03.  Rt forearm today with erythema, redness swelling and warm to the touch.  Patient reported feeling bad and fatiqueed.  Saught tx from PMD
nausea; dizziness; joint pain; headache; lethargy; went to bed for 2 -3 days; went to bed for about 3 days; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection), dose 1 via an unspecified route of administration on 08Mar2021 (Batch/Lot Number: EN6206) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date in Mar2021, the patient experienced nausea, dizziness, joint pain, headache, lethargy and went to bed for 2 -3 days. Patient's second vaccine was scheduled on 29Mar2021. At the time of this report, the outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), in Apr2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 51 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "tuberculosis" (unspecified if ongoing), notes: fully recovered 30 years ago; "uveitis" (unspecified if ongoing); "Known allergies" (unspecified if ongoing), notes: herpes zoster treatment. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course included: The patient previously receives a COVID-19 Vaccine and did not receive other medication in 2 weeks, then patient received treatment with Paxlovid for positive COVID-19 test from Oct2022 to Oct2022. The vaccine administration time was reported as 02:00 PM.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
suspected liver damage; Patterns of diagonal grid-like blood vessels inflammation (similar to livedo reticularis) appeared on left front leg. Faded on its own gradually after two months; elevated level of Alanine Transminase (ALT) at 204 U/L; Aspartate Transaminase (AST) 82 U/L; This is a spontaneous report from a contactable consumer (patient). A 22-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0183), dose 2 via an unspecified route of administration, administered in left arm on 18May2021 at 04:30 hours as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. On an unspecified date, the patient experienced suspected liver damage, patterns of diagonal grid-like blood vessels inflammation (similar to livedo reticularis) appeared on left front leg. Faded on its own gradually after two months. On 25Jun2021, the patient experienced elevated level of alanine transminase (ALT) at 204 U/L and aspartate transaminase (AST) 82 U/L, 5 weeks after receiving second dose of Pfizer COVID vaccine. No personal history of drinking or other suspected cause could be determined that could attribute to this symptom. The patient underwent lab tests and procedures which included alanine aminotransferase: 204 U/L on 25Jun2021, aspartate aminotransferase: 82 U/L on 25Jun2021, alanine aminotransferase: 67 U/L on an unspecified date in Aug2021 without taking medication, aspartate aminotransferase: 42 U/L on an unspecified date in Aug2021 without taking medication, and RT-PCR: negative on 27May2021. The patient did not receive any other vaccine in four weeks. The patient did not receive any treatment for the adverse events. The patient was recovering from the events.
Patient already received a flu vaccine on 10/16/23. This was not discovered until billing was completed (which was after the dose on 10/25/23).
Headache; temperature fluctuations; exhaustion; body aches; upset stomach; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 09:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis since an unknown date. The patient did not have allergy to any medications, food, or other products. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN) taken once a week for rheumatoid arthritis and within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Mar2021, the patient experienced headache, temperature fluctuations, exhaustion, body aches, and upset stomach. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, temperature fluctuations, exhaustion, body aches, and upset stomach was recovered, in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Spoke to Pt who states increased headaches since getting J&J vaccine on 4/9. Pt states h/o headaches but HA normally respond to Motrin. Pt reports taking Motrin 2-4 times since being vaccinated. Pt c/o severe fatigue and nausea. Pt denies SOB, severe leg pain, nor chest pain. Strict ER precautions discussed. Pt scheduled for phone visit.
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history concurrent conditions, drug reactions and allergies were not reported. The patient's concomitant medications included sterile diluent (MERCK STERILE DILUENT) Lot # N013297 and expiration date 25-SEP-2019. On 01-MAY-2018, the patient was vaccinated with an expired dose of VARIVAX for prophylaxis, lot #M005972 and expiration date  02-FEB-2018 (strength, dose, frequency and route of administratin were not reported). No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1805USA002675: US-009507513-1805USA002676:
I can only describe it  seizures. I was laying in bed ready to go to sleep when all the hairs on my body stood up and then it felt like an electric shock went through my body. I had a tremendous ringing in my ears through the event and all my muscles tensed up as my head went back into the pillow. it happened 3 times in a row with only about 30 seconds to a minute between each event.
A lot of pain at the injection. Muscle Pain continued from time of injection to 2/1/2016. Most painful during the first two days (maybe an 8 on a pain scale). Seemed to hurt most in the mornings. Fever + symptoms from 1/26/2016-1/30/2016. 100+ degrees only on first day. Extreme fatigue and weakness during the whole duration. Developed a strenuous cough 1/28/2016-1/30/2016. Discoloration of the skin 1/30/2016-2/1/2016.
Left arm pain that in her shoulder that radiated to her neck and down; Left arm pain that in her shoulder that radiated to her neck and down; Left arm pain that in her shoulder that radiated to her neck and down; Left arm pain that in her shoulder that radiated to her neck and down; This spontaneous case was received on 20-Oct-2020 from other health professional via Health Authority (reference number: SEQW20-03967) and concerned a female patient of unknown age.  The patient's medical history and concomitant medications were not reported.   On 02-Oct-2020, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine, dose: 0.5 ml, anatomical location: left deltoid, route of administration not reported) for influenza prophylaxis. The batch number reported was P100244639 and expiry date 23-Jun-2021.   On unspecified date, an unknown amount of time after vaccination with Afluria Quadrivalent, the patient experienced left arm pain that from shoulder radiated to her neck and down to the forearm.   At the time of initial reporting on 20-Oct-2020, the patient had not recovered from the events.  The reporter did not provide a causality assessment.  The reporter assessed the case as non-serious.  This case is linked with cases 202005333 and 202005339 (the same reporter).  Company comment:The patient developed pain, neck pain, pain in extremity and musculoskeletal pain on an unspecified date after vaccination with Afluria Quadrivalent. Although onset date for these events was not provided, narrative suggested plausible temporal relationship. No information regarding concomitant medications and medical history was provided. Considering all above mentioned, causal relationship for all events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).; Sender's Comments: The patient developed pain, neck pain, pain in extremity and musculoskeletal pain on an unspecified date after vaccination with Afluria Quadrivalent. Although onset date for these events was not provided, narrative suggested plausible temporal relationship. No information regarding concomitant medications and medical history was provided. Considering all above mentioned, causal relationship for all events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).
Myalgia, Arthralgia, Fever, chills, fatigue Narrative:
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 05-OCT-2015, the patient was vaccinated with a dose of improperly stored VAQTA 0.5 ml, intramuscularly, lot # L010468, expiry date 02-NOV-2017 (site of administration was not reported). No adverse effects were reported. Additional information has been requested.
Having significant pain during menstrual cycles now. This is the third month in a row that I have had new and extreme pain in my back. To the point I was physically sick from the pain this last weekend. Doctor's office had me come in and immediately determined this was a side effect of the vaccine.
Covid arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (Covid arm) in a 42-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer Covid vaccine. Past adverse reactions to the above products included No adverse reaction with Pfizer Covid vaccine.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm). At the time of the report, VACCINATION SITE REACTION (Covid arm) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant products reported.  The patient was a nurse. The patient had the Pneumococcal 20 vaccine Prevnar 20 last Wednesday and today as reported woke up and the injection site has little bit of blotchiness with some small bump like almost like a little tiny rash and was wondering if it seemed like the red injection site dermatitis type thing with this vaccine. Patient did have this with Moderna COVID Vaccine and had that like COVID arm but  did not had it with the Pfizer version of the COVID vaccine. It was a week out from that, so patient was thinking something more like a delayed reaction.  No treatment products reported.   Reporter did not allow further contact
Pain on the vaccine site. After that everyday headache until now. Eczema flare up all over his body after the second dose of Moderna.
Information has been received from a Nurse Practitioner concerning a 17-year-old female patient who on 07-AUG-2007 was vaccinated with the first dose of GARDASIL 0.5ml. On 24-JUL-2008 the patient was vaccinated with the second dose of GARDASIL 0.5ml. Two to four weeks after the second after the second dose, the patient experienced developing "hundreds of warts" on her arms legs. Approximately 6 months later the patient recovered. The patient didn't seek medical attention. Additional information has been requested.
Second dose of Moderna vaccination was administered 3 weeks following first dose.  Patient had fever of 101.3 lasting two days and a headache.
Redness, swelling and itching at injection site: 1.5 x 4 cm. Allergic skin reaction; BENADRYL ordered by provider
Weakness, loss of appetite, headache and joint pain x 5 days, pt took Tylenol and rested
Both  times I received the vaccine on the third day I my migraine was triggered and I experienced severe migraines, nausea and vomiting with extreme pain and sensitivity to light and sound. I also experienced severe body pain after both shots. I did not see my physician who I listed but she has notes about my history or migraines.  It was suggested on the CDC tracking app to report here too since my reactions were severe.
Malaise 1 day after nausea/vomiting 2 days after some vomiting but able to eat 3 days after.
onset 9 days after administration of fever to 101 and fussiness, followed by onset 11 days after administration of Proquad of a papular rash that appeared measle-like and included two lesions in the posterior pharynx.  Fever resolved on 12th post vaccine day. Patient treated with acetominophen and diphenhydramine for symptoms.
Information has been received from a physician concerning a 12 year old female who in June 2009, was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL (lot number not reported). Concomitant vaccination included ADACEL. In June 2009, after receiving the vaccination the patient started vomiting and had a fever of 103 degrees. She vomited 20 times in 24 hours. After 24 hours of the vaccination, the patient was then given promethazine and the AE went away. Unspecified medical attention was sought. It was also reported that in August 2009, the patient was vaccinated intramuscularly with the second 0.5ml dose of GARDASIL (lot number not reported). Concomitant vaccination included MENACTRA. Subsequently the patient experienced the same AE. The patient was again given promethazine and the AE went away. The patient stopped to receive the GARDASIL. Follow-up information was received from a employee in the physician's office concerning a 12 year old female patient with a medical history of diabetes insipidus who on 15-JUN-2009 was vaccinated intramuscularly into the arm with the first dose of GARDASIL (lot number 660616/0570X, expired date 02-NOV-2010) and on 21-AUG-2009 was vaccinated intramuscularly into the arm with the second dose of GARDASIL (lot number 661952/1129X, expired date 12-MAR-2011). On 21-AUG-2009 at 18:00 the patient experienced fever, severe vomiting requiring antiemetics. On an unspecified date the patient recovered. Fever and severe vomiting were considered to be an other important medical event by the reporter. Additional information is not expected.
I got the covid booster. Sore arm after the shot (nothing out of the ordinary here). By the evening my neck was getting stiff. I had difficulty sleeping becuase of the stiffness. The next day my neck was very stiff - I can't turn my head to the right or left nor can I tilt my head back. And I noticed that I had lost my sense of smell for most things (for example: meat cooking & orange peels). I was still able to smell urine. I have not had a fever but I have had difficulty sleepin in bed because my neck hurts resting on the pillow. I am able to use a recliner for sleep
Patient developed a slightly productive cough around 7/9. He had associated symptoms of fatigue, myalgias low-grade temperature but no true fever, no associated chest pain or shortness of breath.  Patient is on his ranch with a doctor who prescribed him a 5-day course of levofloxacin.  He was tested for COVID-19 while at the time of his symptoms and 3 days ago. Lingering cough.  He says he has a coughing fit approximately 2-3 times a day with not much productive sputum, but he feels that the cough is improving with each day.  He denies any fevers, chills, headaches, rhinorrhea, sore throat, chest pain, shortness of breath, nausea, vomiting, diarrhea.  Patient says the cough is not very bothersome and he is able to manage it at home.
got the shots and also got shingles/Suspected Vaccination Failure; shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the Shingle shots and also got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting.
Medication error occurred when Pfizer booster dose administered four weeks earlier that six months since primary Pfizer series completion. Pt tolerated administration of vaccine without symptoms or difficulties.
on 1/25 patient experienced dizziness, nausea and vomiting, dizziness worsened the next day. Nausea improved within a day and dizziness resolved fully in one week. According to records reviewed "LINQ device and showed mild arrhythmia but no Afib" MRI brain 1/26/2021: Tiny acute lacunar infarct in the left posterior medulla.
I am in perimenopause/menopause and have not had a menstrual cycle or ovulated for 7 months but I did ovulate a few weeks after having the 2nd dose of vaccine and then recently had spotting (short menstrual cycle)
Nausea,  headache,  body aches, joints and back aches, tiredness
MMR given on 06/05/2013, rash appeared on 06/18/2013. No response to antihistamines. Grandma called office concerned that rash looked like measles although patient remained afebrile. Rash resolved by 2 week f/u.